User profiles for Craig D. Shriver

Craig Shriver

Uniformed Services University of the Health Sciences
Verified email at usuhs.edu
Cited by 43092

[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics

…, DA Levine, AV Lee, L Omberg, DM Wolf, CD Shriver… - Cell, 2018 - cell.com
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …

[PDF][PDF] Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients

…, CE Storrer, C Fisher, CD Shriver… - Journal of Clinical …, 2005 - researchgate.net
Purpose E75 is an immunogenic peptide from the HER2/neu protein that is highly
expressed in breast cancer. We are conducting a clinical trial of an E75 granulocyte-macrophage …

Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas

…, CC Benz, GB Mills, PW Laird, CD Shriver… - JAMA …, 2017 - jamanetwork.com
Importance African Americans have the highest breast cancer mortality rate. Although racial
difference in the distribution of intrinsic subtypes of breast cancer is known, it is unclear if …

[HTML][HTML] Molecular heterogeneity in breast cancer: State of the science and implications for patient care

RE Ellsworth, HL Blackburn, CD Shriver… - Seminars in cell & …, 2017 - Elsevier
The identification of extensive genetic heterogeneity in human breast carcinomas poses a
significant challenge for designing effective treatment regimens. Significant genomic evolution …

Assessing semantic similarity measures for the characterization of human regulatory pathways

X Guo, R Liu, CD Shriver, H Hu, MN Liebman - Bioinformatics, 2006 - academic.oup.com
Motivation: Pathway modeling requires the integration of multiple data including prior
knowledge. In this study, we quantitatively assess the application of Gene Ontology (GO)-derived …

Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories

…, RM Jordan, SJ Russell, CD Shriver - … journal of cancer, 2006 - Wiley Online Library
Matrix metalloproteinase (MMP) 2 and 9 are involved in cancer invasion and metastasis, and
increased levels occur in serum and plasma of breast cancer (BC) patients. It is, however, …

Effect of ASCO/CAP guidelines for determining ER status on molecular subtype

…, R van Laar, C Gallagher, CD Shriver… - Annals of surgical …, 2013 - Springer
Background Determination of estrogen receptor (ER), progesterone receptor (PR), and human
epidermal growth factor receptor 2 (HER2) status is standard for predicting prognosis and …

The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy

…, PC Melder, R Langley, V Bernet, CD Shriver - Thyroid, 2006 - liebertpub.com
Purpose: To evaluate the rapid parathyroid hormone assay (rPTH) as a perioperative tool in
predicting postoperative symptomatic hypocalcemia following thyroidectomy. Methods: We …

[HTML][HTML] Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African …

LA Sturtz, J Melley, K Mamula, CD Shriver… - BMC cancer, 2014 - Springer
Background Although diagnosed less often, breast cancer in African American women (AAW)
displays different characteristics compared to breast cancer in Caucasian women (CW), …

Factors associated with survival disparities between non-Hispanic Black and White patients with uterine cancer

…, TD O'Connor, JH Farley, CD Shriver… - JAMA network …, 2023 - jamanetwork.com
Importance Disparities in survival exist between non-Hispanic Black (hereafter, Black) and
non-Hispanic White (hereafter, White) patients with uterine cancer. Objective To investigate …